Director, Gynecologic Oncology
NYU School of Medicine
Director, Cancer Detection and Screening
Perlmutter Cancer Center
David A. Fishman, M.D joined the faculty of the New York University
School of Medicine on May 1, 2004 as Professor of Obstetrics and Gynecology
and Director of the Division of Gynecologic Oncology. In addition he
is the new Director of the Cancer Screening and Prevention Program of
the Perlmutter Cancer Center.
Dr. Fishman strengthens NYU’s commitment to women’s health
with his compassionate patient care and farsighted research goals. He
is internationally recognized for his innovative research to help find
an effective biomarker for the early detection of ovarian carcinoma.
The National Cancer Institute has funded his National Ovarian Cancer
Early Detection Program for the past five years, and the headquarters
of that program has moved to NYU since his appointment here. He has also
received awards from the American Cancer Society and the Berlex Foundation.
Having received his M.D. from Texas Tech, Dr. Fishman completed his
residency in Obstetrics and Gynecology at Yale University School of Medicine
in 1992. He then continued at Yale to complete a fellowship in Gynecologic
Oncology. Most recently, he was the Vice-Chair of Gynecologic Oncology
Research as well as Professor of Obstetrics and Gynecology at Northwestern
University Medical School.
In addition to his extensive clinical and research pursuits, Dr. Fishman
has been the author of more than 90 scientific papers, and continues to
provide editorial services for a great number of renowned medical and scientific
journals. He is a member of the National Cancer Institute executive committee,
the Society of Gynecologic Oncologists, and the Society for Gynecologic
Investigation. He is frequently invited to lecture worldwide on women’s
cancers and early detection techniques. His recent focus has been on protein
markers for early-stage ovarian cancer, an approach he hopes to apply to
other types of cancer.